National Gynae-Oncology Registry

Purpose / aims: The NGOR is a clinical quality registry that captures data about women with newly diagnosed gynaecological cancers. The registry completed a 2-year pilot of ovarian, tubal and peritoneal cancer module in 2019, and is currently in the process of extending to include cancers of the cervix, vulva, vagina and uterus. The registry monitors care and provides benchmarked reports to clinicians and participating health services demonstrating performance against measures of best practice care, in order to facilitate improvements in quality of care and patient outcomes.
Population captured: All cases of newly diagnosed gynaecological cancers diagnosed and/or treated at participating hospitals across Australia. The list of participating sites is expanding, and can be viewed at ngor.org.au.
Some of the outcomes collected:
  • Appropriateness of disease staging
  • Extent of residual disease remaining after debulking surgery
  • Appropriateness of treatment/care
  • Frequency and type of intraoperative and post-operative complications
Funding sources:
  • The CASS Foundation
  • Ovarian Cancer Australia
  • Australian Society of Gynaecologic Oncologists
  • The Epworth Medical Foundation
Website:ngor.org.au
Registry custodian:Professor John Zalcberg
Head, Cancer Research Program
Registry contact: Ms Natalie Heriot
Email: med-cancerregistries@monash.edu
Phone: +61 3 9903 0435
Clinical lead: Associate Professor Robert Rome
Gynaecological Oncologist, Epworth Healthcare